• Home
  • Stocks
  • Biofil Chemicals & Pharmaceuticals Ltd.

Biofil Chemicals & Pharmaceuticals Ltd.

View in App
51.65 +0.19 ▲0.4%

11 December 2023, 04:01:00 PM
Volume: 3,886

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.biofilgroup.net
Market Cap 84.59 Cr.
Enterprise Value(EV) 84.56 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.41 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 125.32 Trailing Twelve Months Ending 2023-09
Industry PE 38.33 Trailing Twelve Months Ending 2023-09
Book Value / Share 10.86 Trailing Twelve Months Ending 2023-09
Price to Book Value 4.79 Calculated using Price: 51.98
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.63 Cr. 16,273,800 Shares
FaceValue 10
About Biofil Chemicals & Pharmaceuticals Ltd.
Biofil Chemicals & Pharmaceuticals established in 1985, is part of Cyano Group of Industries. The company is into manufacturing of drugs in area of anti-bacterial, analgesics/antipyretics, anti-malarial, anti-psychotics, anti asthmatic/bronchodilators, diuretics, tranquilizer/hypnotics, anti inflammatory, analgesic/antipyretics, anti inflammatory steroids and eye/ear drops

Biofil Chemicals & Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Biofil Chemicals & Pharmaceuticals Ltd. Performance

View details >>
1 Day
+0.37%
1 Week
-3.85%
1 Month
+5.07%
3 Month
+2.24%
6 Month
+14.85%
1 Year
-4.00%
2 Year
-15.60%
5 Year
+632.62%
10 Year
+2851.43%

Biofil Chemicals & Pharmaceuticals Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 13.47 13.28 18.09 3.64 3.60 8.46 8.01 4.24 3.28
Return on Capital Employed (%) 12.97 14.04 21.86 5.13 5.06 10.12 12.18 6.23 4.76
Return on Assets (%) 4.14 4.13 7.81 2.05 1.99 3.63 3.28 2.69 2.24

Biofil Chemicals & Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 8 11 13 13 14 15 16 17 17 18
Non Curr. Liab. 0 0 0 0
Curr. Liab. 5 13 9 11 11 27 17 1 14 24
Minority Int.
Equity & Liab. 14 24 22 24 24 42 33 19 31 42
Non Curr. Assets 9 9 9 9 10 10 10 9 9 9
Curr. Assets 5 15 13 15 14 32 23 9 22 33
Misc. Exp. not W/O
Total Assets 14 24 22 24 24 42 33 19 31 42

Biofil Chemicals & Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 6 13 13 12 23 30 36 22 30 35
Other Income 0 1 0 0 0 0 1 0 0 0
Total Income 6 14 14 12 23 30 37 23 30 35
Total Expenditure -5 -12 -11 -11 -22 -28 -34 -21 -29 -34
PBIDT 1 1 3 1 1 2 2 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 -1 0 0 0 -1 0 0 0
Exceptional Items
PAT 1 1 2 0 0 1 1 1 1 1
Adjusted EPS 0 0 1 0 0 1 1 0 0 0

Biofil Chemicals & Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 1 0 1 1 1 0 0
Cash Fr. Inv. 0 0 0 0 0 -1 0 0 0 0
Cash Fr. Finan. 0 0 0 0 0 0 -1 -1 0 0
Net Change 0 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Biofil Chemicals & Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 46.82 46.82 46.82 46.82 46.82 46.82 46.82 46.82 46.82
Public 53.18 53.18 53.18 53.18 53.18 53.18 53.18 53.18 53.18
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Biofil Chemicals & Pharmaceuticals Ltd. Announcements

View details >>
Fri, 10 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (LODR) Regulations 2015 please find enclosed copies of extract of Un-audited Financial Results for the quarter and half year ended 30th September 2023 published in newspapers i.e. Free Press Mumbai and Indore (In English) and Choutha Sansar (In Hindi) on 10th November 2023. You are requested to please take the same on record.
Fri, 10 Nov 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Information regarding issue of "Letter of Confirmation" in lieu of Share Certificates.
Thu, 09 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 09Th November 2023 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
With reference to the above captioned subject we would like to inform you that Board of Directors of the Company in their meeting (Serial No. 03/2023-24) held on today i.e. Thursday 09th day of November 2023 has inter alia transacted following matters along with other routine businesses: 1. Approval of the Un-Audited Financial Results of the Company for the quarter as well as half year ended on 30th September 2023 along with Segment results Statement of assets and liabilities Cash Flow Statement and Limited Review Report (Copy of Unaudited financial Results for quarter as well as half year ended 30th September 2023 being submitted separately).

Biofil Chemicals & Pharmaceuticals Ltd. Technical Scans

View details >>
Mon, 11 Dec 2023
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Making Higher Highs for 3 days Making Higher Highs for 3 days
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Increase in 1 Month High Increase in 1 Month

Biofil Chemicals & Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 296,485.82 1,235.70 +0.0%
Divi's Laboratories Ltd. 97,380.51 3,668.25 -0.4%
Cipla Ltd. 97,091.96 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. 91,293.11 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. 79,724.28 5,544.70 -0.1%
Mankind Pharma Ltd. 76,862.91 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. 70,227.43 2,075.00 +1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.68 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 73.12 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-09 28.12 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 17.93 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.30 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 59.96 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.64 2,075.00 +1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.96 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 7.68 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-09 3.91 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.58 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.26 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 9.12 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.47 2,075.00 +1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,075.00 +1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,075.00 +1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,075.00 +1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,075.00 +1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,075.00 +1.0%

Biofil Chemicals & Pharmaceuticals Ltd. FAQ's

What is Biofil Chem & Pharma share price?
Can I buy Biofil Chem & Pharma shares now?
What is the Market Cap of Biofil Chem & Pharma?
What are the key metrics to analyse Biofil Chem & Pharma?
What is the 52 Week High and Low of Biofil Chem & Pharma?
What is the trend of Biofil Chem & Pharma share price?